Clinical Trials Browser

Unknown × UNKNOWN × Head & Neck × Clear all

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Phase 2 Unknown

43 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

NCT05136768 2021-11-29

LM-HNSCC

Phase 2 Unknown

50 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT04999800 2021-08-11

Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1

Phase 2 Unknown

20 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT04861467 2021-04-27

Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

155 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01817023 2021-01-29

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

Phase 3 Unknown

590 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03558035 2021-01-29

New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma

Phase 2 Unknown

96 enrolled

Head & Neck

Hypopharyngeal Neoplasms

NCT03975270 2019-07-18

HNSCC

Phase 2 Unknown

41 enrolled

Head & Neck

Head and Neck Squamous Cell Cancer

NCT03744208 2018-11-16

SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

Phase 1/2 Unknown

40 enrolled

Head & Neck

Nasopharyngeal Carcinoma

Clinical Trials

Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

LM-HNSCC

Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1

Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma

HNSCC

SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma